Ferroptosis Induced by Iron Overload in CD8+ T Cells Causes Functional Impairments That Accelerate Endometriosis Progression - Scorecard - MDSpire

Ferroptosis Induced by Iron Overload in CD8+ T Cells Causes Functional Impairments That Accelerate Endometriosis Progression

  • By

  • Shuang Wang

  • Le Xu

  • Xue Jiao

  • Xiaoyu Dong

  • Zhaoyang Zhong

  • Qianhui Ren

  • Xiaoxuan Liu

  • Ming Yuan

  • Guoyun Wang

  • October 27, 2025

  • 0 min

Share

Clinical Scorecard: Ferroptosis Induced by Iron Overload in CD8+ T Cells Causes Functional Impairments That Accelerate Endometriosis Progression

At a Glance

CategoryDetail
ConditionEndometriosis (EM)
Key MechanismsIron overload induces ferroptosis in CD8+ T cells, impairing their function and accelerating EM progression
Target PopulationWomen of reproductive age with stage III–IV endometriosis
Care SettingSpecialist gynecology and immunology research settings

Key Highlights

  • EM lesions exhibit localized iron overload due to periodic bleeding of ectopic endometrial tissue.
  • Excess iron triggers reactive oxygen species generation leading to lipid peroxidation and ferroptosis.
  • Ferroptosis in CD8+ T cells diminishes their activation and cytotoxicity, impairing lesion clearance.

Guideline-Based Recommendations

Diagnosis

  • Confirm EM diagnosis via ultrasound and histopathology.
  • Assess iron overload and immune cell infiltration in eutopic and ectopic endometrial tissues.

Management

  • Consider interventions targeting iron overload and ferroptosis pathways to restore CD8+ T cell function.
  • Adoptive transfer of functional CD8+ T cells may reduce lesion burden.

Monitoring & Follow-up

  • Monitor CD8+ T cell activation status and ferroptosis markers in EM lesions.
  • Evaluate iron levels and oxidative stress markers in affected tissues.

Risks

  • Iron overload may exacerbate inflammatory microenvironment and promote EM progression.
  • Ferroptosis-induced CD8+ T cell dysfunction can impair immune surveillance and lesion clearance.

Patient & Prescribing Data

Women aged 20–49 years with regular menstrual cycles and stage III–IV EM

No direct prescribing data; potential therapeutic strategies include modulation of iron levels and ferroptosis inhibition to restore CD8+ T cell function.

Clinical Best Practices

  • Use minimally invasive tissue sampling for immunohistochemistry and flow cytometry analyses.
  • Employ in vitro and in vivo models to evaluate ferroptosis-targeted interventions.
  • Ensure ethical compliance and humane treatment in animal and human studies.

References

Original Source(s)

Related Content